Global Saliva Collection Devices Market Set to Hit USD 3.82 Billion by 2033 with a 10.4% CAGR Amid Precision Medicine Boom
The future of lifesciences is moving decisively toward non-invasive, patient-centric healthcare transformation. Driven by an unprecedented acceleration in genomics, digital health transformation, and decentralized healthcare delivery, saliva has emerged as a cornerstone biofluid for next-generation diagnostics.

The Global Saliva Collection Devices Market was valued at USD 1.57 Billion in 2024 and is projected to experience a rapid growth trajectory, reaching USD 3.82 Billion by 2033. This expansion re

Global Chronic Lymphocytic Leukemia Market to Cross USD 24.58 Billion by 2032, Propelled by Precision Medicine Boom and Targeted Therapies
The Global Chronic Lymphocytic Leukemia Market was valued at USD 10.64 Billion in 2025 and is projected to reach a valuation of USD 24.58 Billion by 2032, expanding at an impressive CAGR of 12.7% during the forecast period (2026-2032). The global oncology landscape is experiencing a profound paradigm shift driven by genomics, clinical research expansion, and a major transition away from conventional treatments toward highly personalized interventions. At the forefront of this digital he

Global Patient Blood Management Market to Cross USD 9.2 Billion by 2033, Fueled by AI-Driven Healthcare and the Precision Medicine Boom
The Global Patient Blood Management (PBM) Market—valued at USD 5.4 Billion in 2024—is projected to witness a rapid growth trajectory, reaching USD 9.2 Billion by 2033, expanding at a CAGR of 6.1% during the forecast period.the global healthcare ecosystem is undergoing a radical paradigm shift from reactive treatment protocols to proactive, data-driven, and patient-centric precision medicine. At the forefront of this digital health transformation is the rapid evolution of next-generation li

Global Adrenocortical Carcinoma Treatment Market to Reach USD 1,311.89 Million by 2032 from USD 891.73 Million at 5.67% CAGR
The Global Adrenocortical Carcinoma (ACC) Treatment Market is entering a new era of precision oncology, driven by advances in biotechnology, AI-powered healthcare, genomics, and targeted cancer therapies. According to Maximize Market Research (MMR), the market was valued at USD 891.73 Million in 2025 and is projected to reach USD 1,311.89 Million by 2032, expanding at a CAGR of 5.67% during the forecast period. Rising healthcare investments, increasing clinical research, growing incidence of rare

Global Neuroendocrine Tumor Treatment Market to Grow from USD 1.99 Billion to USD 3.91 Billion by 2032 at 10.11% CAGR
Global Neuroendocrine Tumor Treatment Market is entering a transformative growth phase as precision medicine, AI-driven healthcare, biotechnology innovation, and next-generation oncology therapies reshape cancer treatment worldwide. According to Maximize Market Research (MMR), the market was valued at USD 1.99 Billion in 2025 and is projected to reach USD 3.91 Billion by 2032, expanding at a CAGR of 10.11% during the forecast period. Rising investments in pharmaceutical innovation, digital healthcare infra